Publication Name	World Journal of Gastroenterology
Manuscript ID	6801
Country	Singapore

Received	2013-10-29 10:47
Peer-Review Started	2013-10-30 07:59
To Make the First Decision	2013-12-26 11:35
Return for Revision	2013-12-27 15:36
Revised	2014-01-13 15:15
Second Decision	2014-04-09 08:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-04-09 09:02
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-05-14 15:46
Publish the Manuscript Online	2014-05-28 11:45

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: Current status and future prospects
Manuscript Source	Invited Manuscript
All Author List	Yi Lin Jane Tan and Wei Ning Chen
Funding Agency and Grant Number
Corresponding Author	Wei Ning Chen, Professor, School of Chemical and Biomedical Engineering, College of Engineering, Nanyang Technological University, 62 Nanyang Drive, Singapore 637459, Singapore. wnchen@ntu.edu.sg
Key Words	Hepatitis B virus; Hepatitis B virus X protein; Hepatocellular carcinoma; Mechanisms; MicroRNAs; Profiling
Core Tip	Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is a complex cancer of the liver stemming from the long term infection of the virus. MiRNAs are found to be involved in a multitude of events, ranging from the diagnosis, pathogenesis as well as possibly in the treatment of this cancer. This review explores the current knowledge in understanding the role of miRNAs in HBV-related HCC, and how it is able to regulate, or be regulated, such that important cellular processes may be affected.
Publish Date	2014-05-28 11:45
Citation	Tan YLJ, Chen WN. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2014; 20(20): 5973-5986
URL	http://www.wjgnet.com/1007-9327/full/v20/i20/5973.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i20.5973

Full Article (PDF)	WJG-20-5973.pdf
Full Article (Word)	WJG-20-5973.doc
Manuscript File	6801-Review.docx
Answering Reviewers	6801-Answering reviewers.pdf
Copyright License Agreement	6801-Copyright assignment.pdf
Peer-review Report	6801-Peer review(s).pdf
Scientific Editor Work List	6801-Scientific editor work list.doc